Stay updated on GLY-200 Safety in Type 2 Diabetes Clinical Trial

Sign up to get notified when there's something new on the GLY-200 Safety in Type 2 Diabetes Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GLY-200 Safety in Type 2 Diabetes Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-10-31T12:49:50.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology and points visitors to transition updates and FAQs.
    Difference
    0.7%
    Check dated 2026-10-24T13:20:49.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T14:15:21.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-10T15:18:05.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    A new revision label v3.7.0 was added to the record history, and the previous v3.6.6 entry was removed from the list.
    Difference
    0.1%
    Check dated 2026-09-19T18:29:18.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The study record history now includes a new revision entry labeled v3.6.6. The previous entry v3.6.5 was removed, reflecting an update to the record's version history.
    Difference
    0.1%
    Check dated 2026-08-29T18:41:32.000Z thumbnail image

Stay in the know with updates to GLY-200 Safety in Type 2 Diabetes Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GLY-200 Safety in Type 2 Diabetes Clinical Trial page.